1.Ташкенбаева У.А., Алиев А.Ш., Усманалиев С.А. "Встречаемость хронических дерматозов при covid-19 инфекции". Новости дерматовенерологии и репродуктивного здоровья. No 4.2023 (104)2.Ablon G, KoganS. A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair. J Drugs Dermatol. 2018 May 1;17(5):558-565. PMID: 29742189.28,60%31,20%18,60%12,40%9,20%основная группа (n=84)1-2 очага3-5 очагов6-8 очагов9-11 очаговболее 12 очагов3.Aliyev A.S., Mukhamedov B.I., Koldarova E.V., Tashkenbaeva U.A. Comparison of methods for assessing acne severity // Vestnik dermatologii i venerologii. -2022. -Vol. 98. -N. 3. -P. 61-69. doi: 10.25208/vdv13114.Brigelius-Flohé R, ArnérESJ. Selenium and selenoproteins in (redox) signaling, diseases, and animal models -200 year anniversary issue. Free Radic Biol Med. 2018 Nov 1;127:1-2. doi: 10.1016/j.freeradbiomed.2018.09.026. PMID: 30274914.5.Moravvej H, Pourani MR, Baghani M, Abdollahimajd F. Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens. Dermatol Ther. 2021 Jul;34(4):e15004. doi: 10.1111/dth.15004. Epub 2021 Jun 9. PMID: 34033224; PMCID: PMC8209856.6.Trost LB, Bergfeld WF, Calogeras E. The diagnosisand treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006 May;54(5):824-44. doi: 10.1016/j.jaad.2005.11.1104. PMID: 16635664.7.WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-rus.pdf